Medications for Chronic Migraine
For chronic migraine (≥15 headache days per month), topiramate is the first-line preventive medication, followed by onabotulinumtoxinA if topiramate fails, and then CGRP monoclonal antibodies as third-line therapy after failure of at least two other preventive medications. 1, 2
Critical Diagnostic Prerequisite
- Rule out medication overuse headache (MOH) before initiating any preventive therapy, as MOH frequently mimics chronic migraine and will prevent response to preventive medications 1, 2
- MOH occurs when acute medications are used ≥10 days per month and requires withdrawal of overused medications before starting preventive treatment 3, 2
Acute Treatment Medications (Limited Use)
Acute medications must be strictly limited to no more than twice weekly to prevent medication overuse headache 1, 2
First-Line Acute Treatment
- NSAIDs: aspirin, ibuprofen, naproxen sodium, or diclofenac potassium 1, 2
- Combination agent: acetaminophen plus aspirin plus caffeine 1
- Antiemetics: domperidone or metoclopramide when nausea/vomiting is present 1, 2
Second-Line Acute Treatment (When NSAIDs Fail)
- Triptans: naratriptan, rizatriptan, zolmitriptan, or sumatriptan (oral or subcutaneous) 1, 4, 5
- DHE nasal spray 1
- Lasmiditan (selective 5HT1F receptor agonist) 6
- CGRP receptor antagonists (gepants) 6
Medications to Avoid
- Ergot alkaloids, opioids, and barbiturates should be avoided due to questionable efficacy and high risk of dependency and medication overuse headache 2
Preventive Medications: Algorithmic Approach
First-Line Preventive Medications
Topiramate is the drug of first choice due to proven efficacy in chronic migraine and much lower cost compared to biologics 1, 2
Alternative first-line options (though evidence is stronger for episodic migraine than chronic migraine):
- Beta-blockers: propranolol (80-240 mg/day), timolol (20-30 mg/day), atenolol, bisoprolol, or metoprolol 1, 8, 7
- Note: Propranolol increases rizatriptan levels by 70%, requiring dose adjustment 5
- Candesartan 1, 7, 9
Second-Line Preventive Medications
If topiramate fails or is not tolerated:
- Amitriptyline: 30-150 mg/day 1, 7, 10, 9
- Particularly beneficial for patients with depression or sleep disturbances 1
- Flunarizine: 10 mg/day (where available) 1
- Adverse events include sedation, weight gain, depression, and extrapyramidal symptoms in elderly 1
- Divalproex sodium/sodium valproate: 500-1500 mg/day or 800-1500 mg/day 1, 7, 11, 10
- Strictly contraindicated in women of childbearing potential 1
Third-Line Preventive Medications
OnabotulinumtoxinA is indicated after topiramate and at least one other preventive medication have failed 1, 2, 7
- Efficacy should be assessed only after 6-9 months 1
- FDA-approved specifically for chronic migraine prevention 7, 9
CGRP monoclonal antibodies are reserved for patients who have failed at least two or three other preventive medications due to regulatory restrictions and high cost 1, 2
- Erenumab, fremanezumab, and galcanezumab have proven benefit in patients who failed multiple preventive medications 1, 9, 6
- Eptinezumab is also available 1
- Efficacy should be assessed only after 3-6 months 1
Medications with Limited Evidence for Chronic Migraine
No robust data from randomized controlled trials support the use of beta-blockers, candesartan, or amitriptyline specifically for chronic migraine, although they are commonly used in clinical practice 1
Non-Pharmacological Preventive Therapies
These can be used as adjuncts or stand-alone treatments when medications are contraindicated:
- Cognitive-behavioral therapy (CBT) 1, 2, 9
- Biofeedback 1, 2, 9
- Relaxation training 1, 2, 9
- Regular exercise: 40 minutes three times weekly (as effective as topiramate) 3, 2
- Neuromodulatory devices 1, 2
- Acupuncture 1
Nutraceuticals with Fair Evidence
Critical Management Principles
- Start preventive medications at low doses and titrate slowly until clinical benefits are achieved or limited by adverse events 1
- Allow adequate trial period: 2-3 months for oral medications, 3-6 months for CGRP antibodies, 6-9 months for onabotulinumtoxinA 1
- Avoid interfering medications such as overused acute medications during preventive treatment 1
- Consider pausing preventive therapy after 6-12 months of stability to determine if treatment can be stopped 1
- Address comorbidities (depression, anxiety, sleep disorders, obesity, chronic pain) as their management directly improves migraine outcomes 1, 3, 2
Common Pitfalls to Avoid
- Do not initiate preventive therapy without first ruling out and treating MOH 2
- Do not allow unlimited acute medication use - strict limitation to twice weekly prevents progression 2
- Do not abandon treatment prematurely - efficacy may take 2-3 months to manifest 1
- Do not use valproate in women of childbearing potential 1